OncoSweep Cancer Spotlight and Spectrum Product Line

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

May 29, 2023

Primary Completion Date

March 3, 2025

Study Completion Date

May 7, 2025

Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST

OncoSweep Lung Spotligh

This study is to develop and validate the performance of OncoSweep Lung Spotlight for detecting circulating miRNA expression, ctDNA methylation status, platelet RNA, and tumor marker expressions by utilizing real-time polymerase chain reaction (qPCR). The method is to collect venous blood from subjects during their routine visit to the healthcare facilities.

Trial Locations (1)

104217

Mackay Memorial Hospital, Taipei

All Listed Sponsors
lead

Pharus Taiwan, Inc.

INDUSTRY

NCT06261294 - OncoSweep Cancer Spotlight and Spectrum Product Line | Biotech Hunter | Biotech Hunter